Poslední aktualizace :
19/11/2024
Antibiotikas   Cefamandole nafate  
Įpurškimas
Tirpalų stabilumas Mišinių stabilumas Stabilumą lemiantys veiksniai Suderinamumas Leidimo būdai Bibliografija pdf
   Cheminė sandara  

Prekinis pavadinimas   Prekinis pavadinimas     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Acemycin Graikija
Cefam Italija, Vengrija
Cefamandol Liuksemburgas
Cefamandolo Italija
Cemado Italija
Kefadol Airija
Kefandol Didžioji Britanija, Marokas
Lampomandol Italija
Mancef Italija
Mandokef Austrija, Graikija, Italija, Šveicarija, Vengrija
Mandol Australija, Jungtiniai Arabų Emyratai, Liuksemburgas, Naujojoje Zelandijoje, Olandija
Mandolsan Italija
Septomandolo Italija
Tarcefandol Lenkija
Bibliografija   Įpurškimas   Bibliografija : Cefamandole nafate  
tipas leidinys
198 Žurnalas Gayed AA, Kheshary PR, Hinkle RL.
Visual compatibility of diltiazem injection with various diluents and medications during simulated Y-site injection.
Am J Health-Syst Pharm 1995 ; 52: 516-520.
336 Žurnalas Forman JK, Lachs JR, Souney PF.
Visual compatibility of acyclovir sodium with commonly used intravenous drugs during simulated Y-site injection.
Am J Hosp Pharm 1987 ; 44: 1408-1409.
385 Žurnalas Benedict MK, Roche VF, Banakar UV, Hilleman DE.
Visual compatibility of amiodarone hydrochloride with various antimicrobial agents during simulated Y-site injection.
Am J Hosp Pharm 1988 ; 45: 1117-1118.
405 Žurnalas Nieves-Cordero AL, Luciw HM, Souney PF.
Compatibility of narcotic analgesic solutions with various antibiotics during simulated Y-site injection.
Am J Hosp Pharm 1985 ; 42: 1108-1109.
406 Žurnalas Smythe MA, Patel MA, Gasloli RA.
Visual compatibility of narcotic analgesics with selected intravenous admixtures.
Am J Hosp Pharm 1990 ; 47: 819-820.
418 Žurnalas Bosso JA, Townsend RJ.
Stability of clindamycin phosphate and ceftizoxime sodium, cefoxitine sodium, cefamandole nafate, or cefazolin sodium in two intravenous solutions.
Am J Hosp Pharm 1985 ; 42: 2211-2214.
472 Žurnalas Wohlford JG, Fowler MD.
Visual compatibility of hetastarch with injectable critical-care drugs.
Am J Hosp Pharm 1989 ; 46: 995-996.
574 Žurnalas Kleinberg ML, Stauffer GL, Prior RB, Latiolais CJ.
Stability of antibiotics frozen and stored in disposable hypodermic syringes.
Am J Hosp Pharm 1980 ; 37: 1087-1088.
576 Žurnalas Holmes CJ, Ausman RK, Walter CW, Kundsin RB.
Activity of antibiotic admixtures subjected to different freeze-thaw treatments.
Drug Intell Clin Pharm 1980 ; 14: 353-357.
604 Laboratorija Stabilité des médicaments dans l'Intermate® SV50, 100, 200
Baxter 1998
612 Žurnalas Frable RA, Klink PR, Engel GL, Mundell EE.
Stability of cefamandole nafate injection with parenteral solutions and additives.
Am J Hosp Pharm 1982 ; 39: 622-627.
630 Žurnalas Das Gupta V, Stewart KR.
Stability of metronidazole and ten antibiotics when mixed with magnesium sulphate solutions.
J Clin Hosp Pharm 1985 ; 10: 67-72.
999 Žurnalas Watson D.
Piggyback compatibility of antibiotics with pediatric parenteral nutrition solution.
JPEN 1985 ; 9: 220-224.
1035 Žurnalas Bisaillon S, Sarrazin R.
Compatibility of several antibiotics or hydrocortisone when added to metronidazole solution for intravenous infusion.
J Parenter Sci Technol 1983 ; 37: 129-132.
1047 Žurnalas Souney PF, Colucci RD, Mariani G, Campbell D.
Compatibility of magnesium sulfate solutions with various antibiotics during simulated Y-site injection.
Am J Hosp Pharm 1984 ; 41: 323-324.
1057 Žurnalas Cutie MR.
Compatibility of verapamil hydrochloride injection with commonly used additives.
Am J Hosp Pharm 1983 ; 40: 1205-1207.
1165 Žurnalas Bowtle WJ, Heasman MJ, Prince AP, Easthope DA.
Compatibility of the cephalosporin, cefamandole nafate with injections.
Int J Pharm 1980 ; 4: 263-265.
1201 Žurnalas Yuhas EM, Lofton FT, Rosenberg HA, Mayron D, Baldinus JG.
Cimetidine hydrochloride compatibility III: Room temperature stability in drug admixtures.
Am J Hosp Pharm 1981 ; 38: 1919-1922.
1232 Žurnalas Beatson C, Taylor A.
A physical compatibility study of furosemide & flucloxacillin injections.
Br J Pharm Pract 1987 ; 9: 223-226, 236.
1479 Žurnalas Digel S.
Cefamandolnafat und metronidazol. Chemische stabilität in einer mischung zur intravenösen infusion.
Krankenhauspharmazie 1995 ; 1: 9-12.
3520 Laboratorija Cidomycin - Summary of product Chracteristics.
Sanofi 2011
3526 Laboratorija Clindamycin (Dalacin®) - Summary of Product Characteristics
Pharmacia 2010
3546 Laboratorija Cefamandole Flavelab - Résumé des caractéristiques du produit
Panpharma SA 2007
3549 Laboratorija Amikacine B Braun - Résumé des caractéristiques du produit.
B Braun 2012
3594 Laboratorija Metronidazole (Flagyl®) - Summary of Product Characteristics
Zentiva 2013
3643 Laboratorija Gentamicin sulphate (Cidomycin®) - Summary of Product Characteristics
Sanofi 2015
3644 Laboratorija Calcium gluconate® - Summary of Product Characteristics
Hameln Pharmaceuticals 2010
3674 Laboratorija Erythromycin lactobionate - Summary of Product Characteristics
PanPharma 2016

  Mentions Légales